Chakrabarti is new to the role, having started in early December, but the potential he gives UMass Medical School for new innovation and business development is clear.
Chakrabarti held leadership roles with some major industry firms, including Amgen, Johnson & Johnson Innovation and Sanofi Genzyme. Partnerships, especially with higher education, are more central to how these companies like to operate. And the Worcester school should have more potential than ever in that realm, particularly with life science firms looking to expand westward from Boston.
